REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $661 | +7.0% | 25 | 0.0% | 0.00% | – |
| Q2 2022 | $618 | -25.5% | 25 | 0.0% | 0.00% | – |
| Q1 2022 | $830 | +1.5% | 25 | 0.0% | 0.00% | – |
| Q4 2021 | $818 | -21.9% | 25 | 0.0% | 0.00% | – |
| Q3 2021 | $1,048 | +7.9% | 25 | 0.0% | 0.00% | – |
| Q2 2021 | $971 | +13.8% | 25 | 0.0% | 0.00% | – |
| Q1 2021 | $853 | -24.8% | 25 | 0.0% | 0.00% | – |
| Q4 2020 | $1,134 | +64.8% | 25 | 0.0% | 0.00% | – |
| Q3 2020 | $688 | -75.1% | 25 | -66.7% | 0.00% | – |
| Q2 2020 | $2,762 | +13.7% | 75 | 0.0% | 0.00% | – |
| Q1 2020 | $2,429 | -66.1% | 75 | -57.1% | 0.00% | -100.0% |
| Q4 2019 | $7,170 | +15.1% | 175 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,230 | -40.8% | 175 | -14.6% | 0.00% | 0.0% |
| Q2 2019 | $10,531 | +93.4% | 205 | +115.8% | 0.00% | 0.0% |
| Q1 2019 | $5,444 | +159.5% | 95 | +90.0% | 0.00% | – |
| Q4 2018 | $2,098 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |